Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Streaming Portfolio Company Safety Strips, Provides Corporate Update (click to learn more) Saturn Oil & Gas Inc. Announces $525 Million Accretive Core-Area Saskatchewan Asset Acquisition (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Instil Bio Inc TIL

Healthcare Biotechnology
Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a... see more

Recent & Breaking News (NDAQ:TIL)

IIROC Trading Halt - TIL

Canada NewsWire December 2, 2019

Till Capital Ltd. Announces IGCs Execution of a Share Purchase Agreement for the Sale of the Malmyzh Copper-Gold Porphyry Project

Filing Services Canada June 14, 2018

Till Capital Ltd. to Voluntarily Delist its Restricted Voting Shares from Nasdaq and Deregister with the SEC

GlobeNewswire April 13, 2018

Till Capital Announces Normal Course Issuer Bid

GlobeNewswire April 5, 2018

Till Capital Reports IG Copper Drill Campaign Underway at Malmyzh and Engagement of Scotiabank

GlobeNewswire March 5, 2018

Till Announces Resignation of Director

GlobeNewswire December 4, 2017

Till Announces Investment Banking Engagements to Market Certain Assets

GlobeNewswire November 14, 2017

Till Capital Ceases to be an Insider of DeepMarkit Corp.

GlobeNewswire October 10, 2017

Till Capital Reports Results of Annual General Meeting

GlobeNewswire August 21, 2017

Till Capital Ltd. Files U.S. GAAP Restated Quarterlies

GlobeNewswire April 28, 2017

Till Files 2016 Annual Financial Statements – Provides Update on Filing of U.S. GAAP Restated Quarterlies

GlobeNewswire April 17, 2017

Till Capital 2016 Annual Financial Statement Filing Delayed

GlobeNewswire March 29, 2017

Till Capital Ltd. Reports Sale of Shares of Encore Energy Corp.

GlobeNewswire February 17, 2017

Till Capital Announces Change of Auditor

GlobeNewswire February 3, 2017

Till Capital Decreases Holding of enCore Energy Corp.

GlobeNewswire January 19, 2017

Till Capital Announces Normal Course Issuer Bid

GlobeNewswire December 1, 2016

Till Capital Announces Q3 2016 Results, Appoints Tilton and Rohlinger to Board

GlobeNewswire November 14, 2016

Till Capital Announces Results of Annual General Meeting

GlobeNewswire August 24, 2016

Till Capital Reports 2nd Quarter 2016 Operational and Financial Results

GlobeNewswire August 12, 2016

Till Capital Reports Government Approval to Advance the Malmyzh Copper-Gold Project, Far East Russia, Owned 51% by IG Copper LLC, A Till Portfolio Company

GlobeNewswire July 25, 2016